Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
While experts support the FDA's fight against misinformation, they warn that separate controversies at the agency may be undermining its credibility with the public. → Read More
The overdose-reversing drug naloxone should be made available over the counter to aid the national response to the opioid crisis, U.S. health advisers said. → Read More
Gay and bisexual men in monogamous relationships could soon be able to donate blood for the first time in decades. → Read More
The Food and Drug Administration on Monday proposed a simplified approach so that most adults and children would get a once-a-year shot against COVID-19. → Read More
It's the first drug that’s been convincingly shown to slow the decline in memory and thinking that define Alzheimer's disease, but comes with potential risks. → Read More
The FDA's rule change broadens availability of abortion pills to many more pharmacies, including large chains and mail-order companies. → Read More
Under a recent law, the National Institutes of Health will begin spending about $25 million to enroll patients in open access programs of unapproved drugs. → Read More
The same group of neurology experts narrowly voted against the drug in March, due to concerns about missing data and implementation errors in the company’s study. → Read More
Advocates predict the hearing aid market will eventually resemble eye care, where consumers can choose between drugstore reading glasses or prescription bifocals. → Read More
The unusual step is an acknowledgment that the U.S. currently lacks the supplies needed to vaccinate everyone seeking protection from the rapidly spreading virus. → Read More
Health departments in some major cities don’t have enough shots to meet demand and have stopped scheduling appointments for second vaccine doses to stretch supplies. → Read More
Pfizer and Moderna already were brewing and testing boosters updated against the first omicron mutant in anticipation of an October rollout. → Read More
If regulators clear the shots by Pfizer or Moderna, vaccinations could begin as soon as next week. → Read More
The company's first step will be to produce more specialty formula for babies with allergies or digestive problems. → Read More
The majority of the blame for the U.S. baby formula shortfall is being placed on a massive recall, but is this really the case? → Read More
Here are the reasons behind the shortage — and what the FDA plans to do about it. → Read More
The FDA said it decided to restrict Johnson & Johnson's COVID-19 vaccine after taking another look at data on the risk of life-threatening blood clots. → Read More
The flavor ban could save lives by helping current smokers quit. African Americans buy the largest share of menthol cigarettes. → Read More
The projected cost of Aduhelm was a major driver behind a $22 increase in Medicare’s Part B premium this year. → Read More
The newest booster expansion may not be the last: Next week, the government will hold a public meeting to debate if everyone eventually needs a fourth COVID dose. → Read More